glp-1 and thyroid Implications of Receptor Agonist on Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality TSH Levels Current human data do not
Description
Cinnamon: Known for balancing blood sugar and supporting digestion
Women in menopause are turning to GLP1 weight-loss drugs

On July 25, 2023, China National Medical Products Administration (NMPA) approved Beinaglutide Injection (Feisumei), a glucagon-like peptide-1 receptor agonist (GLP-1-RA), for weight loss.

Inphase 3 clinical trials (SURPASS 1-5), the dose-dependent efficacy and safety of tirzepatide were assessed by once-weekly subcutaneous injection (5mg, 10mg, and 15 mg), as monotherapy or combination therapy, in individuals with T2DM

Note: it is a food supplement it does not contain or act like GLP-1 medication